FDA Inspection
Reproductive Medicine InstituteReproductive Medicine Institute – FDA Inspection, Nov 14, 2018
Record Details
This FDA Inspection record concerns Reproductive Medicine Institute, with an inspection on November 14, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d695808e-ab6b-4651-ad37-68fe824fa294
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1073855
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
Other FDA inspections of Reproductive Medicine Institute
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 9, 2026 | Not classified | Chicago District Office | |
| January 18, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Reproductive Medicine Institute
- FDA Inspection 1306640 - 2026-03-09
- FDA Inspection 814339 - 2013-01-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.